
Hoon K. Song
Examiner (ID: 2067, Phone: (571)272-2494 , Office: P/2884 )
| Most Active Art Unit | 2884 |
| Art Unit(s) | 2882, 2884 |
| Total Applications | 2660 |
| Issued Applications | 2252 |
| Pending Applications | 149 |
| Abandoned Applications | 297 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20386573
[patent_doc_number] => 12486290
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-02
[patent_title] => Isoindolinone and indazole compounds for the degradation of EGFR
[patent_app_type] => utility
[patent_app_number] => 19/205510
[patent_app_country] => US
[patent_app_date] => 2025-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 134503
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 386
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19205510
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/205510 | Isoindolinone and indazole compounds for the degradation of EGFR | May 11, 2025 | Issued |
Array
(
[id] => 19682247
[patent_doc_number] => 20250000792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-02
[patent_title] => DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS
[patent_app_type] => utility
[patent_app_number] => 18/883447
[patent_app_country] => US
[patent_app_date] => 2024-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46548
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18883447
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/883447 | DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS | Sep 11, 2024 | Pending |
Array
(
[id] => 19784089
[patent_doc_number] => 20250057768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-20
[patent_title] => LIPID-BASED COATING COMPOSITION, AND AN OBJECT HAVING A LIPID-BASED COATING
[patent_app_type] => utility
[patent_app_number] => 18/826571
[patent_app_country] => US
[patent_app_date] => 2024-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7104
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18826571
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/826571 | LIPID-BASED COATING COMPOSITION, AND AN OBJECT HAVING A LIPID-BASED COATING | Sep 5, 2024 | Pending |
Array
(
[id] => 19629609
[patent_doc_number] => 20240408058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-12
[patent_title] => COMPOSITIONS FOR THE EFFECTIVE TREATMENT OF VITAMIN C DEFICIENCY-RELATED DISEASES AND OTHER CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 18/809240
[patent_app_country] => US
[patent_app_date] => 2024-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36906
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 279
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18809240
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/809240 | COMPOSITIONS FOR THE EFFECTIVE TREATMENT OF VITAMIN C DEFICIENCY-RELATED DISEASES AND OTHER CONDITIONS | Aug 18, 2024 | Pending |
Array
(
[id] => 19777386
[patent_doc_number] => 12226406
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-18
[patent_title] => Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea
[patent_app_type] => utility
[patent_app_number] => 18/795711
[patent_app_country] => US
[patent_app_date] => 2024-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26142
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18795711
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/795711 | Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea | Aug 5, 2024 | Issued |
Array
(
[id] => 19599463
[patent_doc_number] => 20240390343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-28
[patent_title] => COMPOSITIONS OF 1-(4-BROMO-5-(1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL)-2-FLUOROPHEYL)-3-PHENYLUREA
[patent_app_type] => utility
[patent_app_number] => 18/795683
[patent_app_country] => US
[patent_app_date] => 2024-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26127
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18795683
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/795683 | Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea | Aug 5, 2024 | Issued |
Array
(
[id] => 19599465
[patent_doc_number] => 20240390345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-28
[patent_title] => COMPOSITIONS OF 1-(4-BROMO-5-(1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL)-2-FLUOROPHEYL)-3-PHENYLUREA
[patent_app_type] => utility
[patent_app_number] => 18/795731
[patent_app_country] => US
[patent_app_date] => 2024-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26155
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18795731
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/795731 | Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea | Aug 5, 2024 | Issued |
Array
(
[id] => 20509950
[patent_doc_number] => 20260034048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-02-05
[patent_title] => STABILIZATION OF AVOBENZONE IN COSMETIC SUNSCREENS
[patent_app_type] => utility
[patent_app_number] => 18/790794
[patent_app_country] => US
[patent_app_date] => 2024-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18790794
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/790794 | STABILIZATION OF AVOBENZONE IN COSMETIC SUNSCREENS | Jul 30, 2024 | Pending |
Array
(
[id] => 19743926
[patent_doc_number] => 20250032491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-30
[patent_title] => AMORPHOUS NILOTINIB MICROPARTICLES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/791209
[patent_app_country] => US
[patent_app_date] => 2024-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35932
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18791209
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/791209 | AMORPHOUS NILOTINIB MICROPARTICLES AND USES THEREOF | Jul 30, 2024 | Pending |
Array
(
[id] => 19947036
[patent_doc_number] => 12318374
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-03
[patent_title] => Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea
[patent_app_type] => utility
[patent_app_number] => 18/758007
[patent_app_country] => US
[patent_app_date] => 2024-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21900
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18758007
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/758007 | Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea | Jun 27, 2024 | Issued |
Array
(
[id] => 20082956
[patent_doc_number] => 20250212892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-03
[patent_title] => USE OF THERMALLY HYDROLYZED KERATIN PEPTIDE SOLUTION IN ENHANCING THE YIELD AND QUALITY OF TEA LEAVES
[patent_app_type] => utility
[patent_app_number] => 18/758140
[patent_app_country] => US
[patent_app_date] => 2024-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18758140
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/758140 | USE OF THERMALLY HYDROLYZED KERATIN PEPTIDE SOLUTION IN ENHANCING THE YIELD AND QUALITY OF TEA LEAVES | Jun 27, 2024 | Pending |
Array
(
[id] => 20082957
[patent_doc_number] => 20250212893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-03
[patent_title] => METHOD FOR PROMOTING THE GROWTH OF COTTON UNDER LOW TEMPERATURE STRESS
[patent_app_type] => utility
[patent_app_number] => 18/758198
[patent_app_country] => US
[patent_app_date] => 2024-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18758198
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/758198 | METHOD FOR PROMOTING THE GROWTH OF COTTON UNDER LOW TEMPERATURE STRESS | Jun 27, 2024 | Pending |
Array
(
[id] => 19510497
[patent_doc_number] => 20240342183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => LAMOTRIGINE ORAL LIQUID SUSPENSION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/752293
[patent_app_country] => US
[patent_app_date] => 2024-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10151
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18752293
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/752293 | Lamotrigine oral liquid suspension and use thereof | Jun 23, 2024 | Issued |
Array
(
[id] => 19629817
[patent_doc_number] => 20240408266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-12
[patent_title] => WOUND DRESSING, WOUND GEL AND COSMETIC
[patent_app_type] => utility
[patent_app_number] => 18/748428
[patent_app_country] => US
[patent_app_date] => 2024-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4181
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18748428
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/748428 | WOUND DRESSING, WOUND GEL AND COSMETIC | Jun 19, 2024 | Pending |
Array
(
[id] => 19768275
[patent_doc_number] => 20250049701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => SILK-BASED ARTICLES HAVING VARIABLE ACTIVE AGENT RELEASE RATES
[patent_app_type] => utility
[patent_app_number] => 18/746604
[patent_app_country] => US
[patent_app_date] => 2024-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10933
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18746604
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/746604 | SILK-BASED ARTICLES HAVING VARIABLE ACTIVE AGENT RELEASE RATES | Jun 17, 2024 | Pending |
Array
(
[id] => 19510401
[patent_doc_number] => 20240342087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => TARGETED EXTRACELLULAR VESICLES COMPRISING MEMBRANE PROTEINS WITH ENGINEERED GLYCOSYLATION SITES
[patent_app_type] => utility
[patent_app_number] => 18/731681
[patent_app_country] => US
[patent_app_date] => 2024-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17802
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18731681
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/731681 | TARGETED EXTRACELLULAR VESICLES COMPRISING MEMBRANE PROTEINS WITH ENGINEERED GLYCOSYLATION SITES | Jun 2, 2024 | Pending |
Array
(
[id] => 19570268
[patent_doc_number] => 20240374560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => FIBER-ENHANCED LIPOSOME AND METHODS
[patent_app_type] => utility
[patent_app_number] => 18/662189
[patent_app_country] => US
[patent_app_date] => 2024-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9430
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18662189
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/662189 | FIBER-ENHANCED LIPOSOME AND METHODS | May 12, 2024 | Pending |
Array
(
[id] => 19707915
[patent_doc_number] => 20250018057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-16
[patent_title] => METHODS OF TREATMENT OF HLA-B27 RELATED INFLAMMATORY DISEASES AND COMPOSITIONS RELATED TO SAME
[patent_app_type] => utility
[patent_app_number] => 18/657698
[patent_app_country] => US
[patent_app_date] => 2024-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7264
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18657698
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/657698 | METHODS OF TREATMENT OF HLA-B27 RELATED INFLAMMATORY DISEASES AND COMPOSITIONS RELATED TO SAME | May 6, 2024 | Pending |
Array
(
[id] => 19540987
[patent_doc_number] => 20240358023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => Agricultural Composition and Method of Making the Same
[patent_app_type] => utility
[patent_app_number] => 18/644744
[patent_app_country] => US
[patent_app_date] => 2024-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4363
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18644744
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/644744 | Agricultural Composition and Method of Making the Same | Apr 23, 2024 | Pending |
Array
(
[id] => 19379448
[patent_doc_number] => 20240269318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => NANO-DELIVERY SYSTEMS COMPRISING MODIFIED LIPIDS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/626620
[patent_app_country] => US
[patent_app_date] => 2024-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30908
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18626620
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/626620 | NANO-DELIVERY SYSTEMS COMPRISING MODIFIED LIPIDS AND USE THEREOF | Apr 3, 2024 | Pending |